Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study.
Saved in:
| Title: | Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study. |
|---|---|
| Authors: | Greenberg BR; Division of Hematology-Oncology, University of Connecticut Health Center, Farmington 06030., Reynolds RD, Charron CB, Squillace KM, Lessin LS, Case DC Jr, Gams RA |
| Source: | Cancer [Cancer] 1993 Mar 15; Vol. 71 (6), pp. 1989-92. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 8443750 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Greenberg+BR%22">Greenberg BR</searchLink>; Division of Hematology-Oncology, University of Connecticut Health Center, Farmington 06030.<br /><searchLink fieldCode="AU" term="%22Reynolds+RD%22">Reynolds RD</searchLink><br /><searchLink fieldCode="AU" term="%22Charron+CB%22">Charron CB</searchLink><br /><searchLink fieldCode="AU" term="%22Squillace+KM%22">Squillace KM</searchLink><br /><searchLink fieldCode="AU" term="%22Lessin+LS%22">Lessin LS</searchLink><br /><searchLink fieldCode="AU" term="%22Case+DC+Jr%22">Case DC Jr</searchLink><br /><searchLink fieldCode="AU" term="%22Gams+RA%22">Gams RA</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 1993 Mar 15; Vol. 71 (6), pp. 1989-92. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0008-543X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=8443750 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1097-0142(19930315)71:6<1989::aid-cncr2820710611>3.0.co;2-t Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1989 Titles: – TitleFull: Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I-II study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Greenberg BR – PersonEntity: Name: NameFull: Reynolds RD – PersonEntity: Name: NameFull: Charron CB – PersonEntity: Name: NameFull: Squillace KM – PersonEntity: Name: NameFull: Lessin LS – PersonEntity: Name: NameFull: Case DC Jr – PersonEntity: Name: NameFull: Gams RA IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 03 Text: 1993 Mar 15 Type: published Y: 1993 Identifiers: – Type: issn-print Value: 0008-543X Numbering: – Type: volume Value: 71 – Type: issue Value: 6 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |